FDA Drug Application (022511) for VIMOVO by HORIZON PHARMA USA

Back to FDA Applications sponsored by HORIZON PHARMA USA

Application Number022511
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
DosageEQ 20MG BASE;500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVIMOVO
Active IngredientESOMEPRAZOLE MAGNESIUM; NAPROXEN



Back to FDA Applications sponsored by HORIZON PHARMA USA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.